Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Merck
McKesson
Mallinckrodt
Express Scripts

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Children's Cetirizine Hydrochloride Hives Relief, and when can generic versions of Children's Cetirizine Hydrochloride Hives Relief launch?

Children's Cetirizine Hydrochloride Hives Relief is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Athem, Aurobindo Pharma, Cypress Pharm, Lannett Co Inc, Perrigo R And D, Pharm Assoc, Ranbaxy Labs Ltd, Taro, Torrent, Tris Pharma Inc, Jubilant Generics, and Sun Pharm. and is included in fifteen NDAs.

The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-four suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

Summary for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Drug patent expirations by year for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Recent Clinical Trials for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hamad Medical CorporationPhase 1
Stefania La Grutta, MDPhase 4
Medical Universtity of LodzPhase 4

See all CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF clinical trials

Synonyms for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
(+-)-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid, dihydrochloride
(+) {2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazine-1-yl] -ethoxy}-acetic acid dihydrochloride
(+/-)-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]acetic acid, dihydrochloride
(+/-){2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]-ethoxy}-acetic acid dihydrochloride
(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid dihydrochloride
(R)-2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride
(RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy }-acetic acid dihydrochloride
(RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy}-acetic acid dihydrochloride
[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]aceticaciddihydrochloride
130018-82-5
2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrichloride
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanoic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
83881-51-0 (Parent)
83881-52-1
881C510
A840675
AB0008484
AB1009381
AC-1600
AC1L1IJL
Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride
Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)-
AKOS000280979
AKOS016340521
Alercet
Alergex
Alerid
Alerlisin
Alertisin
Allergy relief
Alleroff
AN-14770
ANW-69482
API0001938
Apo-Cetirizine
AX8022801
BCP09018
BG0436
C21H25ClN2O3.2HCl
C21H27Cl3N2O3
CAS-83881-52-1
CC0256
CCG-213404
Cetalerg
Ceterifug
Ceti TAD
Ceti-Puren
Cetiderm
Cetidura
Cetil von ct
CetiLich
Cetirigamma
Cetirizin AZU
Cetirizin Basics
Cetirizin dihydrochloride, >=98.0% (HPLC)
Cetirizine (dihydrochloride)
Cetirizine Di
Cetirizine diHCl
Cetirizine dihydrochloride
Cetirizine Dihydrochloride 1.0 mg/ml in Water (as free base)
Cetirizine dihydrochloride solution, 1.0 mg/mL in acetonitrile: water (9:1) (as free base), ampule of 1 mL, certified reference material
Cetirizine dihydrochloride, >=98% (HPLC)
Cetirizine dihydrochloride, European Pharmacopoeia (EP) Reference Standard
Cetirizine dihydrochloride, United States Pharmacopeia (USP) Reference Standard
Cetirizine for peak identification, European Pharmacopoeia (EP) Reference Standard
Cetirizine HCl
CETIRIZINE HYDROCHLORIDE
Cetirizine hydrochloride (JP17/USAN)
Cetirizine hydrochloride [USAN:USP]
Cetirizine hydrochloride [USAN]
Cetirizine Hydrochloride Allergy
Cetirizine Hydrochloride Hives
Cetirizine hydrochloride, British Pharmacopoeia (BP) Reference Standard
Cetirizine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
cetirizinedihydrochloride
Cetirlan
Cetriler
Cetrine
Cetzine
Cezin
CHEBI:3562
CHEMBL1607273
Children's Cetirizine hydrochloride allergy
Children's Zyrtec
Children's Zyrtec Allergy
Children's Zyrtec Hives Relief
CS-1798
CTK8C2999
D00664
DSSTox_CID_24268
DSSTox_GSID_44268
DSSTox_RID_80138
DTXSID2044268
Formistin
FT-0603000
HMS1569F07
HMS1922H04
HY-17042A
I06-0389
J10151
KS-000015AD
KS-1042
LP00362
LS-11411
MolPort-000-832-941
NCGC00016949-01
NCGC00095180-01
NCGC00095180-02
NCGC00255965-01
NCGC00261047-01
NCGC00263567-01
P 071
P-071
PGLIUCLTXOYQMV-UHFFFAOYSA-N
Prestwick_841
Reactine
Ressital
Riztec
RTR-026026
Ryzen
s1291
Salvalerg
SCHEMBL41107
Setiral
SPECTRUM1505371
SR-01000688282
SR-01000688282-3
ST077146
ST24039138
Stopaler
Sun mark all day allergy
SW196972-3
Topcare all day allergy
Tox21_110704
Tox21_110704_1
Tox21_302261
Tox21_500362
Triz
UCB-P 071
Up and up all day allergy relief
Virdos
Voltric
Xero-sed
Zerviate
Zetir
Zirtin
Zyrtec
Zyrtec (TN)
Zyrtec Allergy
Zyrtec Hives Relief
Zyrtec-D
Zyrzine

US Patents and Regulatory Information for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090378-001 May 9, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo R And D CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090254-001 Apr 9, 2008 OTC No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090750-001 Feb 2, 2010 OTC No No   Start Trial   Start Trial   Start Trial
Torrent CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090474-001 Mar 30, 2009 OTC No No   Start Trial   Start Trial   Start Trial
Pharm Assoc CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090188-001 Apr 22, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 090142-003 Aug 30, 2011 OTC No No   Start Trial   Start Trial   Start Trial
Jubilant Generics CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 091116-003 Feb 19, 2015 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Moodys
Merck
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.